Crawford Investment Counsel’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.4M Sell
187,506
-10,880
-5% -$518K 0.18% 105
2025
Q4
$7.41M Sell
198,386
-19,250
-9% -$782K 0.12% 129
2025
Q3
$8.81M Sell
217,636
-18,499
-8% -$611K 0.15% 120
2025
Q2
$6.03M Buy
236,135
+4,840
+2% +$106K 0.11% 138
2025
Q1
$4.94M Buy
231,295
+29,550
+15% +$660K 0.09% 152
2024
Q4
$4.24M Buy
201,745
+36,100
+22% +$835K 0.08% 155
2024
Q3
$3.73M Buy
+165,645
New +$3.2M 0.06% 159

Other funds holding PAHC

Crawford Investment Counsel's PAHC Position: Q1 2026 in Review

Crawford Investment Counsel reduced its Phibro Animal Health (PAHC) stake by 5.5% in Q1 2026, selling an estimated $518K and leaving 187,506 shares worth $10.4M. The position accounts for 0.18% of the portfolio, ranked #105.

Crawford Investment Counsel first reported a position in PAHC in Q3 2024 and has held it in 7 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Crawford Investment Counsel held 187,506 shares of Phibro Animal Health worth $10.4M as of Q1 2026.
  • Crawford Investment Counsel sold 10,880 Phibro Animal Health shares in Q1 2026, an estimated $518K.
  • Phibro Animal Health made up 0.18% of Crawford Investment Counsel's portfolio in Q1 2026, its #105 holding.
  • Crawford Investment Counsel first reported a position in Phibro Animal Health in Q3 2024 and has held it in 7 quarters since.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.